Asterion
Asterion: 3rd Generation Biopharmaceuticals | ProFuse | Third-generation AFT.
Launch date
Employees
Market cap
-
Enterprise valuation
€2—4m (Dealroom.co estimates May 2006.)
Company register number 04129500
Sheffield England (HQ)
Financials
Estimates*
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
| Profit | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
$680k | Seed | ||
| Total Funding | €618k | ||
Recent News about Asterion
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.